GlassScriptPhysician profile
Jack W Grinnan
NPI 1487090288
$7,647.14
in general payments reported to CMS, 2019-2025
44 companies · $1,885 in 2025
The $1,885 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $666 · 2020: $233 · 2021: $995 · 2022: $1,171 · 2023: $1,370 · 2024: $1,328 · 2025: $1,885.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,493 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,492.52 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $836.05 | 2019-2025 | Xtandi, Myrbetriq |
| Abbvie INC. | $591.01 | 2019-2025 | |
| Coloplast Corp | $589.47 | 2019-2025 | Titan, Speedicath |
| Procept Biorobotics Corporation | $455.61 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Blue Earth Diagnostics | $433.26 | 2019-2025 | Posluma |
| Pfizer INC. | $379.43 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $330.88 | 2023-2025 | Orgovyx, Gemtesa |
| Antares Pharma, INC. | $322.14 | 2019-2024 | Xyosted, Nocdurna, Tlando |
| Janssen Biotech, INC. | $318.03 | 2019-2025 | Erleada, Akeega |
| Ferring Pharmaceuticals INC. | $285.56 | 2024-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $266.78 | 2020-2025 | |
| Myriad Genetic Laboratories, INC. | $245.33 | 2020-2023 | Prolaris |
| Progenics Pharmaceuticals, INC. | $234.38 | 2022-2025 | Pylarify |
| Boston Scientific Corporation | $222.49 | 2019-2025 | Ams 700, Greenlight Xps |
| Calyxo, INC. | $220.33 | 2024-2025 | Cvac Aspiration System |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $198.29 | 2019-2025 | Bard Urinary Drainage Bag, Purewick Female External Catheter |
| Laborie Medical Technologies Corp. | $167.75 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter, Eclipse |
| 180 Medical, INC. | $160.38 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $151.01 | 2019-2025 | Provenge |
| Urogen Pharma, INC. | $144.10 | 2022-2025 | Jelmyto |
| Endo Pharmaceuticals INC. | $118.41 | 2020-2024 | Xiaflex, Aveed |
| Allergan, INC. | $102.89 | 2019 | |
| Novartis Pharmaceuticals Corporation | $91.11 | 2024-2025 | |
| Teleflex LLC | $88.77 | 2022-2023 | Urolift |
| Smith+Nephew, INC. | $87.32 | 2021-2025 | Stravix Pl |
| Baxter Healthcare | $65.04 | 2023-2024 | Floseal, Tisseel |
| Endo USA, INC. | $51.84 | 2024-2025 | Xiaflex, Aveed |
| Travere Therapeutics, INC. | $49.72 | 2020-2022 | |
| Neotract INC. | $46.06 | 2019 | |
| Axonics, INC. | $45.80 | 2022-2023 | Axonics |
| Tolmar Pharmaceuticals, INC. | $44.07 | 2020-2022 | |
| Tolmar, INC. | $41.80 | 2023-2024 | |
| Olympus America INC. | $38.51 | 2023-2025 | Itind System |
| Halozyme INC | $29.58 | 2023 | |
| Palette Life Sciences, INC. | $28.23 | 2023 | |
| Alnylam Pharmaceuticals INC. | $26.52 | 2023 | Givlaari |
| Medtronic, INC. | $25.65 | 2023 | Interstim |
| Merck Sharp & Dohme LLC | $24.25 | 2022 | |
| Bioprotect Medical, INC. | $19.83 | 2025 | Bioprotect Balloon Implant System |
| Innovation Technologies INC | $18.35 | 2024 | Irrisept |
| Abc Home Medical Supply, INC. | $13.99 | 2025 | |
| Photocure INC | $12.94 | 2022 | |
| Myovant Sciences INC. | $12.58 | 2022 | |
| Acerus Pharmaceuticals Corporation | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Grinnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.